Jingkun Qu
277 West Yanta Road
Xi'an, 710061, China
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Association between four indirect indicators of insulin resistance and lung cancer: evidence from UK biobank and Mendelian randomization analysis.
Journal: BMC cancer
Published: December 01, 2025
Erratum: Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization.
Journal: American journal of cancer research
Published: June 03, 2025
Response to Neoadjuvant Systemic Therapy May Serve as an Indicator for Omitting Post-BCS Radiation Therapy in Women with Early-Stage Breast Cancer.
Journal: Cancer research and treatment
Published: June 01, 2025
Editorial Expression of Concern: Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.
Journal: Clinical and experimental medicine
Published: April 21, 2025
Options for postoperative radiation therapy in patients with de novo metastatic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: February 26, 2025
Random survival forest predicts survival in patients with metastatic laryngeal and hypopharyngeal cancer and the prognostic benefits of surgery and radiotherapy.
Journal: Journal of Cancer
Published: August 01, 2024
Machine learning-based prognostic models and factors influencing the benefit of surgery on primary lesion for patients with lung cancer brain metastases.
Journal: American journal of cancer research
Published: June 24, 2024
Recent Advances in Smart Linkage Strategies for Developing Drug Conjugates for Targeted Delivery.
Journal: Topics in current chemistry (Cham)
Published: June 11, 2024
The current diagnosis and treatment strategy of breast cancer based on multicentre retrospective data in Shaanxi province.
Journal: World journal of surgical oncology
Published: March 28, 2024
CD39 inhibitor (POM-1) enhances radiosensitivity of esophageal squamous cell carcinoma (ESCC) cells by promoting apoptosis through the Bax/Bcl-2/Caspase 9/Caspase 3 pathway.
Journal: International immunopharmacology
Published: February 04, 2024
Last Updated: 09/26/2026